The Pharmacogenomics (PGx) Project Group has developed peer-reviewed online education for healthcare practitioners to advance pharmacogenomics in clinical practice. The activities below can be taken independently either free of charge or for continuing education credit depending upon the learner’s needs. The content is reviewed annually and the series is hosted online by the University of Pittsburgh.
Author: Spoorthy Reddy, BS.
External Reviewers: Christina Aquilante, Pharm.D. and Kathleen Giacomini, Ph.D.
This module educates healthcare professionals about pharmacogenomics nomenclature and how to apply pharmacogenomics information into clinical decision making.
Authors: Philip Empey, Pharm.D., Ph.D. and Ben Brown, B.S.
External Reviewers: Kelly Caudle, Pharm.D., Ph.D. and Wendy Rubinstein, M.D., Ph.D.
This module educates healthcare professionals about evidence-based pharmacogenomic resources from the Food and Drug Administration (FDA), the Clinical Pharmacogenetics Implementation Consortium (CPIC), and the Pharmacogenomics Knowledgebase (PharmGKB).
Practical Aspects of Pharmacogenomics Implementation
Authors: Otito Frances Iwuchukwu, PharmD, PhD and Jenny Nguyen, PharmD, APh, BCPS
External Reviewers: Natasha Petry, PharmD, BCACP and Vivian K. Kawai, MD, MPH
This module educates healthcare professionals about what elements are involved in implementing a simple population-focused, pharmacogenomic program.
Direct-to-Consumer Pharmacogenomic Testing
Author: Roseann S. Donnelly (Gammal), PharmD, BCPS
External Reviewers: Cyrine-Elaina Haidar, PharmD, BCPS, BCOP, FASHP and David Kisor, PharmD, FCP
This module educates healthcare professionals towards a better understanding of the benefits and limitations of direct-to-consumer pharmacogenomic testing, when to pursue confirmatory clinical testing, and how to interpret pharmacogenomic test results using evidence-based resources.
Authors: Emili Leary, Pharm.D. and Philip Empey, Pharm.D., Ph.D.
External Reviewers TBD
This module educates healthcare professionals about core concepts in pharmacogenomic testing including the differences between genotyping and sequencing, limitations of testing, and the regulatory landscape. Important factors are included to guide clinicians through selecting a testing laboratory, informed consent, and interpretation of test results.
Economics of Pharmacogenomic Testing
Author: Karen Niemchick, Ph.D.
External Reviewers Joshua Peterson, M.D. and Caleb Bupp, M.D.
This module provides a case study to demonstrate treatment regimen decisions through cost-benefit analysis based on genetic testing, individual patient medical information, and risk factors.
Navigating PGx Test Coverage in Medicare Populations
Authors: Ben Brown, BS, Christine Formea, Pharm.D., and Sara Rogers, Pharm.D.
External Reviewers TBD
This module explores key components of payer coverage guidance for pharmacogenomic testing.
Genotype-Guided Clopidogrel Treatment
Author: Andrew A. Monte, M.D., Ph.D.
External Reviewers Dan Roden, M.D. and Alan Shuldiner, M.D.
This module educates healthcare professionals about the impact of pharmacogenomic variability on clopidogrel effectiveness through a review of guidelines and case-based activities.
Optimization of Psychiatric Treatment with Pharmacogenomics
Authors: Keegan Hovland, BS; Andy Eugene, M.D., Ph.D., Daniel Mueller, M.D.
External Reviewers Chad Bousman, Ph.D. and Matthew Logalbo, M.D.
This module describes common genes associated with the effectiveness and safety of psychiatric medications as well as the impact of drug-drug interactions (phenoconversion) through case-based activities.
Videos from Healthcare Professionals' Genomics Education Week
Introducing the NIH Inter-Society Coordinating Committee for Practitioner Education in Genomics (ISCC-PEG) Pharmacogenomics Learning Series: New Peer-Reviewed Online Education for Healthcare Professionals
ISCC-PEG Pharmacogenomics Project Group
June 6, 2023
Last updated: September 25, 2023